| Literature DB >> 33343401 |
Jinxiang Liu1,2,3, Zan Li1, Yujue Wang1, Quanqi Zhang1,2,3.
Abstract
Ringer's or phosphate buffer saline (PBS) solution buffer usually was used as dilution butter in intraperitoneal injection. Stress could activate immune response, inflammatory response and glycogen metabolic process. The impact of solution buffer as a stressor to immune system was ignored in immunostimulatory experiment. In this report, we tested the hypothesis that the innate immune response and glycogen metabolic process were altered when it were challenged with Ringer's in Japanese flounder (Paralichthys olivaceus). RNA-seq was performed after challenge with Ringer's at 8 h and 48 h. The data revealed that the expression profiles of blood, gill, and kidney were significantly changed. Differentially expressed genes (DEGs) were identified, and energy metabolic and immune-related genes were up-regulated or down-regulated obviously. GO and KEGG analyses showed that DEGs were mainly enriched in innate immune terms and pathways. Weighted gene co-expression networks analysis (WGCNA) also indicated the highest association module with stress. A total of 16 genes were detected in the gray module, which were immune-related and metabolic-related genes. These results provided fundamental information on intraperitoneal injection with solution buffer. It offered useful clues to further explore the functional mechanism of stress and immunity.Entities:
Keywords: RNA-seq; Ringer’s; glycolysis; immune response; stress
Year: 2020 PMID: 33343401 PMCID: PMC7746848 DOI: 10.3389/fphys.2020.612036
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Summary statistics of transcriptome sequencing data.
| Sample | Raw reads | Clean reads | Q30 | Mapped reads ratio (%) |
| BL-BC-1 | 39386050 | 38249960 | 96.61 | 85.4 |
| BL-BC-2 | 37893132 | 36471298 | 96.25 | 86.2 |
| BL-8h-1 | 38968468 | 37891324 | 96.87 | 84.8 |
| BL-8h-2 | 43018882 | 42167744 | 96.53 | 85.6 |
| BL-48h-1 | 43378088 | 41847770 | 96.93 | 86.7 |
| BL-48h-2 | 34815162 | 33693164 | 96.66 | 85.1 |
| G-BC-1 | 46623232 | 44808810 | 96.09 | 84.0 |
| G-BC-2 | 35757094 | 34188358 | 96.36 | 83.1 |
| G-8h-1 | 37358864 | 36658130 | 96.54 | 84.2 |
| G-8h-2 | 44639998 | 43288968 | 96.42 | 83.5 |
| G-48h-1 | 50302230 | 49194286 | 96.33 | 81.7 |
| G-48h-2 | 46566514 | 44290268 | 96.34 | 83.2 |
| K-BC-1 | 34654974 | 33660130 | 96.54 | 81.8 |
| K-BC-2 | 43336872 | 41552026 | 96.49 | 80.6 |
| K-8h-1 | 48870804 | 47839838 | 96.71 | 80.0 |
| K-8h-2 | 41977128 | 39794424 | 96.37 | 82.0 |
| K-48h-1 | 32195342 | 31520502 | 96.38 | 85.1 |
| K-48h-2 | 40873152 | 39124050 | 96.33 | 80.3 |
FIGURE 1MA plot analysis between BC group vs. 8 h and BC group vs. 48 h post injection in blood, gill, and kidney. BC, blank control; BL, blood; G, gill; K, kidney.
FIGURE 2Venn diagram shown the numbers of expressed genes and DEGs in different tissues after challenged with Ringer’s. (A) DEGs in blood. (B) DEGs in gill. (C) DEGs in kidney.
FIGURE 3GO enrichment analysis of DEGs in different tissues. DEGs were annotated to different GO terms. (A) GO enrichment of DEGs in blood at 8 h and 48 h post injection. (B) GO enrichment of DEGs in gill at 8 h and 48 h post injection. (C) GO enrichment of DEGs in kidney at 8 h and 48 h post injection.
DEGs associated with immune response in blood.
| Gene | Annotation | |
| RBL | L-rhamnose-binding lectin CSL2-like | 5.00E-05 |
| MRC2 | C-type mannose receptor 2 | 5.00E-05 |
| SIG15 | Sialic acid-binding Ig-like lectin 15 | 0.003 |
| TLR5 | Toll-like receptor 5 | 0.0001 |
| PRS57 | Serine protease 57 | 0.0076 |
| CLC5A | C-type lectin domain family 5 member A | 5.00E-05 |
| TCB | T-cell receptor beta, type 1 | 5.00E-05 |
| CCL2 | C-C motif chemokine 2 | 0.01115 |
| XLOC_009588 | Galectin-3-like | 0.0036 |
| CD2 | T-cell surface antigen CD2-like isoform X1 | 0.00245 |
| NITR | Novel immune-type receptor | 5.00E-05 |
| IL21R | interleukin-21 receptor-like isoform X1 | 5.00E-05 |
| HHLA2 | HERV-H LTR-associating protein 2-like | 5.00E-05 |
| Nfkbid | NF-kappa-B inhibitor delta-like | 0.01315 |
| CD81 | CD81 antigen | 0.01425 |
| TLR5 | Toll-like receptor 5 | 5.00E-05 |
| TNIP1 | TNFAIP3-interacting protein 1-like | 0.00525 |
| MRC2 | C-type mannose receptor 2 | 0.00215 |
| IL17RB | Interleukin-17 receptor B | 5.00E-05 |
| TLR2 | Toll-like receptor 2 | 5.00E-05 |
| TLR1 | Toll-like receptor 1 | 5.00E-05 |
| CD9 | CD9 antigen | 0.0016 |
| CLEC | C-lectin-A | 0.0001 |
| XLOC_002185 | Immunoglobulin light chain 2 | 0.00345 |
| NLRC3 | NOD-like receptor C | 5.00E-05 |
| TNFRSF11 | Tumor necrosis factor receptor superfamily member 11A | 0.01615 |
| TLR3 | Toll-like receptor 3 | 0.0002 |
| APOL6 | Apolipoprotein L6 | 5.00E-05 |
| XLOC_013403 | Galactose-specific lectin nattectin | 5.00E-05 |
| IL21R | Interleukin-21 receptor | 5.00E-05 |
| APOL3 | Apolipoprotein L6 | 5.00E-05 |
| TLR7 | Toll-like receptor 7 | 0.0013 |
| CCL20 | C-C motif chemokine 20 | 0.0102 |
DEGs associated with immune response in gill.
| Gene | Annotation | |
| CLEC3A | C-type lectin domain family 3 member A | 5.00E-05 |
| CCL4 | C-C motif chemokine 4 | 0.01045 |
| SOX10 | Transcription factor SOX-10 | 5.00E-05 |
| IL34 | Interleukin-34 | 0.0198 |
| CCL20 | C-C motif chemokine 20 | 0.0022 |
| BCAP31 | B-cell receptor-associated protein 31 | 5.00E-05 |
| B2L12 | Bcl-2-like protein 12 | 5.00E-05 |
| TLR5 | Toll-like receptor 5 | 5.00E-05 |
| TNFRSF1A | Tumor necrosis factor receptor superfamily member 1A | 0.0171 |
| IL13R2 | Interleukin-13 receptor subunit alpha-2 | 5.00E-05 |
| FCGBP | IgGFc-binding protein | 5.00E-05 |
| HHLA2 | HERV-H LTR-associating protein 2-like | 5.00E-05 |
| SOCS5 | Suppressor of cytokine signaling 5 | 0.00405 |
| CASP9 | Caspase-9 | 5.00E-05 |
| CD276 | CD276 antigen | 5.00E-05 |
| CCL4 | C-C motif chemokine 4 | 0.0022 |
| LAG3 | Lymphocyte activation gene 3 protein | 5.00E-05 |
| SOCS3 | Suppressor of cytokine signaling 3 | 5.00E-05 |
| CCL19 | C-C motif chemokine 19 | 5.00E-05 |
| RORA | Nuclear receptor ROR-alpha | 0.0041 |
| NPNT | Nephronectin | 5.00E-05 |
| NAL12 | NACHT, LRR and PYD domains-containing protein 12 | 0.00265 |
| CD276 | CD276 antigen | 5.00E-05 |
| CCL20 | C-C motif chemokine 20 | 0.0117 |
DEGs associated with immune response in kidney.
| Gene | Annotation | |
| GLEC | Galactose-specific lectin nattectin-like | 0.02125 |
| TNIP1 | TNFAIP3-interacting protein 1 | 0.0008 |
| XLOC_012310 | Immunoglobulin light chain 2 | 5.00E-05 |
| TUSC2 | Tumor suppressor candidate 2 | 0.00705 |
| HSP60 | Heat shock protein 60 kDa | 5.00E-05 |
| CD81 | CD81 antigen | 5.00E-05 |
| IL21R | Interleukin-21 receptor | 5.00E-05 |
| CD34 | Hematopoietic progenitor cell antigen CD34 | 0.01775 |
| CD59 | CD59 glycoprotein-like isoform X1 | 5.00E-05 |
| VSIG1 | V-set and immunoglobulin domain-containing protein 1 | 0.00035 |
| TLR13 | Toll-like receptor 13 | 5.00E-05 |
| IL11 | Interleukin-11 | 0.0222 |
| XLOC_012310 | Immunoglobulin light chain 2 | 5.00E-05 |
| BOKA | Bcl-2-related ovarian killer protein homolog A | 5.00E-05 |
| ISLR2 | Immunoglobulin superfamily containing leucine-rich repeat protein 2 | 5.00E-05 |
| IGSF8 | Immunoglobulin superfamily member 8 | 5.00E-05 |
| CD9 | CD9 antigen | 0.0038 |
| IL8 | Interleukin-8 | 5.00E-05 |
| HSPB | Heat shock protein beta-1 | 5.00E-05 |
| CD28 | T-cell-specific surface glycoprotein CD28 | 5.00E-05 |
| IGSF3 | Immunoglobulin superfamily member 3 | 0.002 |
| CD97 | CD97 antigen | 5.00E-05 |
| CD109 | CD109 antigen | 5.00E-05 |
| IGLL5 | Immunoglobulin lambda-like polypeptide 5 | 5.00E-05 |
| TLR9 | Toll-like receptor 9 | 5.00E-05 |
| IL17RB | Interleukin-17 receptor B | 0.0009 |
| TLR8 | Toll-like receptor 8 | 5.00E-05 |
| CD2 | T-cell surface antigen CD2 | 5.00E-05 |
| CD82 | CD82 antigen | 5.00E-05 |
| CD267 | CD276 antigen homolog | 5.00E-05 |
| TCB2 | T-cell receptor beta, type 2 | 5.00E-05 |
| SIK2 | Serine/threonine-protein kinase SIK2 | 5.00E-05 |
| TNIP1 | TNFAIP3-interacting protein 1 | 0.00795 |
| TLR5 | Toll-like receptor 5 | 5.00E-05 |
| NLRC | NOD-like receptor C | 5.00E-05 |
| IL5RA | Interleukin-5 receptor subunit alpha Interleukin-1 receptor | 5.00E-05 |
| IL1RAPL1B | Accessory protein-like 1-B-like isoform X4 | 0.00975 |
| VSIG1 | V-set and immunoglobulin domain-containing protein 1 | 0.00205 |
| SERP1 | Stress-associated endoplasmic reticulum protein 1 | 5.00E-05 |
| TLX1 | T-cell leukemia homeobox protein 1 | 5.00E-05 |
FIGURE 4KEGG enrichment analysis of DEGs in different tissues. (A) KEGG enrichment in blood. (B) KEGG enrichment in gill. (C) KEGG enrichment in kidney.
FIGURE 5WGCNA analysis of the expressed genes. (A) Gene clustering tree (dendrogram) obtained by hierarchical clustering of adjacency-based dissimilarity. The colored row below the dendrogram indicates module membership identified by the dynamic tree cut method with module colors. (B) Module-feature associations. Each row corresponds to a module eigengene and each column to a trait. Each cell contains the corresponding correlation in the first line and the P-value in the second line. The table is color-coded by correlation according to the color legend.
Genes selected by WGCNA.
| Gene | GS. Stress | |
| Retrotransposable element Tf2 155 kDa protein type 1 | –0.873974332 | 2.14E-06 |
| RNA-directed DNA polymerase from mobile element jockey | –0.867444433 | 3.14E-06 |
| Zinc finger protein 45-like | 0.839499762 | 1.32E-05 |
| Unnamed protein product | 0.78839998 | 0.000101502 |
| Transposable element Tc1 transposase | –0.677349714 | 0.002013609 |
| Myotubularin-related protein 7-like | –0.625467925 | 0.00550202 |
| Probable RNA-directed DNA polymerase from transposon BS | –0.58350611 | 0.011018785 |
| Interferon alpha-inducible protein 27 | –0.539770239 | 0.02077184 |
| NUAK family SNF1-like kinase 2-like | 0.489045795 | 0.039434092 |
| Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like | –0.477034255 | 0.045311857 |
| Interferon alpha-inducible protein 27-like protein 2B like isoform X2 | 0.428551042 | 0.075992385 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | 0.338264183 | 0.169757729 |
| Uncharacterized protein | 0.319036231 | 0.196904352 |
| Neurexin-2-alpha-like | 0.281091058 | 0.258508817 |
| Interferon regulatory factor 3 variant 1 | –0.189081435 | 0.452392985 |
| Gamma-sarcoglycan-like | 0.118463534 | 0.639662611 |
FIGURE 6Verification of the fold change both in qRT-PCR and FPKM after Ringer’s injection. (A–C) The fold change of DEGs in blood at 8 h and 48 h post injection. (D–F) The fold change of DEGs in gill at 8 h and 48 h post injection. (G–I) The fold change of DEGs in kidney at 8 h and 48 h post injection.